ilmscore | Pharma / Drug Exclusivity Predictions
N/A
Accuracy

Recent Predictions

Total: 1
Correct: 0
Incorrect: 0
Pending: 1
Prediction
Author
Predicted at
Status
Video
Pharma companies are predicted to be able to replace 50-100% of the revenue/profit lost from Revlimid generic expiry through new approvals, but not exceed Revlimid's current contribution.
"some of them might replace 70% of what they lose in rev limit some companies might at best replace 1..."
Apr 24, 2025
Pending